Newborn Screening Market is expected to grow at a CAGR of 8.3% during the forecast period. Newborn Screening Market is expected to reach US$ 2.08 Bn. by 2029. For the past 60 years, advances in science and technology, increased consumer activism, the activities of doctors involved in the treatment of rare illness patients, and federal and state government financing and legislation have driven progress in newborn screening (NBS). The present surge in clinical trials for therapies for uncommon diseases has increased the need for development, and concerns regarding the capacity for advancement and improvement are being expressed. Genome and Exome sequencing (GS/ES) have now opened up new opportunities for illness detection and prevention at all stages of life. The greatest problem for NBS is that scientists are screening for uncommon genetic illnesses, which are the ones most receptive to screening and innovative therapy development. Moreover, comprehending the severity range necessitates massive volumes of demographic and genetic data. Molecular tests in NBS are now transitioning from functional testing with limited result interpretation difficulties to germline testing to find therapeutically actionable targets. Molecular testing can be used in conjunction with biochemical tests as second-tier tests in the screening algorithm or to control predictive values of screens, decrease follow-up costs to families and the health care system (false-positive screens), and guide therapy in emergent newborn conditions. The etiologies of hundreds of uncommon diseases have been discovered by 2022, allowing for the creation of precise diagnostics and therapies. The molecular basis of 6925 illnesses has been identified to date. A total of 4470 genes have disease-causing variations, making them genetically testable. The initial databases of genome sequences in world populations have continued to evolve, while their interpretations of uncommon harmful disease variations and diverse population data remain restricted. After quickly developing during the last decade, the pipeline for novel medicines and biologics is still expanding. For example, Zolgensma, the first gene therapy for an NBS disorder, became accessible shortly after Spinraza was approved by the FDA, resulting in the inclusion of SMA in NBS. The first SCD patient was treated with clustered regularly interspaced short palindromic repeats (CRISPR) CAS 9 gene substitution therapy in 2020. Even if these medicines are for uncommon conditions, there have been fears that they would become prohibitively expensive, since Zolgensma costs around $2.2 million for a one-dose therapy. The responsibilities of government, families, and health care professionals have been crucial to the creation of NBS programs and their support, particularly in policy formulation. Some of the leading key players in the global Newborn Screening market include A GE Healthcare, Masimo Corporation, and Medtronic. They are continuously strategizing on mergers and acquisitions, strategic alliances, joint ventures, and partnerships for the growth of their market shares.To know about the Research Methodology:-Request Free Sample Report The newborn screening market is segmented into the products, test type, technology, and region. In terms of products, the global newborn screening market is classified into new-born screening instruments, and new-born screening reagents & assay kits. Based on the test type, the global newborn screening market is divided into the hearing screen test, critical congenital heart disease test, and dry blood spot test. A further technology, global newborn screening market is split hearing screen technology, electrophoresis, tandem mass spectrometry, pulse Oximetry technology, DNA based assays, and enzymes & immunoassay. Based on regions, the global newborn screening market is divided into five main regions are America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The newborn screening market is mainly used for the detection & diagnosis of diseases that mainly occur in infants & newborn babies. Diseases in newborn babies generally include biotinidase deficiency, congenital hypothyroidism, congenital adrenal hyperplasia, congenital toxoplasmosis, cystic fibrosis, and homocystinuria. Screening is done within a few days of birth or before leaving the hospital and in some countries, there is a second screening done at 1-2 weeks of age. In terms of product, the instruments market accounts for the largest share of the global products market, followed by reagents and assay kits. The new-born screening instruments are further sub-segmented into newborn disorder screening, newborn hearing screening, and Pulse Oximetry. The instruments segment is dominating the market owing to the wide usage of newborn screening devices across the globe, the increasing chromosomal abnormalities in infants, growing awareness in urbanized nations and a rising panel of newborn infections. Reagents & assay kits segment is expected to hold major revenue share, owing to increasing number of blood tests life conducted and blood samples stored for future use. Based on test type, dry blood spot test is a major segment and it is majorly used for clinical & pre-clinical pharmacokinetic studies, taking advantage of smaller sampling needs & simplified sample collection & handling. Dry blood spot test testing is a simple method of collecting, shipping and storing blood samples. On the basis of region global newborn screening market divided into five regions such as Asia Pacific, North America, Europe, Latin America, and Middle East Africa. Among all the regions, the Asia Pacific had the xx% market share in 2022 and is projected to lead the market during the forecast period. Because of increased birth rate, government programs supporting newborn screening, increasing prevalence of diseases in newborn babies, and increasing prevalence of birth defects. Key players operating in global newborn screening market are AB Sciex, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Covidien PLC, GE Healthcare, Masimo Corporation, Medtronic Inc, Natus Medical Incorporated, PerkinElmer Inc, Trivitron Healthcare, Waters Corporation, and ZenTech S.A. The objective of the report is to present comprehensive analysis of Global Newborn Screening Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Newborn Screening Market dynamics, structure by analyzing the market segments, and project the Global Newborn Screening Market size. Clear representation of competitive analysis of key players by Global Newborn Screening Market Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Newborn Screening Market make the report investor’s guide.
Newborn Screening Market Scope: Inquire before buying
Newborn Screening Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.19 Bn. Forecast Period 2023 to 2029 CAGR: 8.3 % Market Size in 2029: US $ 2.08 Bn. Segments Covered: by Products New-born screening instruments New-born screening Reagents & Assay kits by Test Type Hearing screen test Critical congenital heart disease Test Dry blood spot test by Technology Hearing screen technology Electrophoresis Tandem Mass Spectrometry Pulse Oximetry Technology DNA based assays Enzymes & Immunoassay Newborn Screening Market, by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players Operating In Newborn Screening Market:
1. AB Sciex 2. Agilent Technologies Inc 3. Bio-Rad Laboratories Inc 4. Covidien PLC 5. GE Healthcare 6. Masimo Corporation 7. Medtronic Inc 8. Natus Medical Incorporated 9. PerkinElmer Inc 10.Trivitron Healthcare 11.Waters Corporation 12.ZenTech S.A Frequently Asked Questions: 1] What segments are covered in the Newborn Screening Market report? Ans. The segments covered in the Newborn Screening Market report are based on Products, Test Type, Technology. 2] Which region is expected to hold the highest share in the Newborn Screening Market? Ans. The Asia Pacific region is expected to hold the highest share in the Newborn Screening Market. 3] What is the market size of the Newborn Screening Market by 2029? Ans. The market size of the Newborn Screening Market by 2029 is US$ 2.08 Bn. 4] What is the forecast period for the Newborn Screening Market? Ans. The forecast period for the Newborn Screening Market is 2023-2029. 5] What was the market size of the Newborn Screening Market in 2022? Ans. The market size of the Newborn Screening Market in 2022 was US$ 2.08 Bn.
Global Newborn Screening Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Newborn Screening Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.4. Global Newborn Screening Market Industry Trends and Emerging Technologies 5. Global Newborn Screening Market Analysis and Forecast 5.1. Global Newborn Screening Market Analysis and Forecast 5.2. Global Newborn Screening Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Newborn Screening Market Analysis and Forecast, by Products 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Newborn Screening Market Value Share Analysis, by Products 6.4. Global Newborn Screening Market Size (US$ Mn) Forecast, by Products 6.5. Global Newborn Screening Market Analysis, by Products 6.6. Global Newborn Screening Market Attractiveness Analysis, by Products 7. Global Newborn Screening Market Analysis and Forecast, by Test Type 7.1. Introduction and Definition 7.2. Global Newborn Screening Market Value Share Analysis, by Test Type 7.3. Global Newborn Screening Market Size (US$ Mn) Forecast, by Test Type 7.4. Global Newborn Screening Market Analysis, by Test Type 7.5. Global Newborn Screening Market Attractiveness Analysis, by Test Type 8. Global Newborn Screening Market Analysis and Forecast, by Technology 8.1. Introduction and Definition 8.2. Global Newborn Screening Market Value Share Analysis, by Technology 8.3. Global Newborn Screening Market Size (US$ Mn) Forecast, by Technology 8.4. Global Newborn Screening Market Analysis, by Technology 8.5. Global Newborn Screening Market Attractiveness Analysis, by Technology 9. Global Newborn Screening Market Analysis, by Region 9.1. Global Newborn Screening Market Value Share Analysis, by Region 9.2. Global Newborn Screening Market Size (US$ Mn) Forecast, by Region 9.3. Global Newborn Screening Market Attractiveness Analysis, by Region 10. North America Newborn Screening Market Analysis 10.1. Key Findings 10.2. North America Newborn Screening Market Overview 10.3. North America Newborn Screening Market Value Share Analysis, by Products 10.4. North America Newborn Screening Market Forecast, by Products 10.4.1. New-born screening instruments 10.4.2. New-born screening Reagents & Assay kits 10.5. North America Newborn Screening Market Value Share Analysis, by Test Type 10.6. North America Newborn Screening Market Forecast, by Test Type 10.6.1. Hearing screen test 10.6.2. Critical congenital heart disease Test 10.6.3. Dry blood spot test 10.7. North America Newborn Screening Market Value Share Analysis, by Technology 10.8. North America Newborn Screening Market Forecast, by Technology 10.8.1. Hearing screen technology 10.8.2. Electrophoresis 10.8.3. Tandem Mass Spectrometry 10.8.4. Pulse Oximetry Technology 10.8.5. DNA based assays 10.8.6. Enzymes & Immunoassay 10.9. North America Newborn Screening Market Value Share Analysis, by Country 10.10. North America Newborn Screening Market Forecast, by Country 10.10.1. The U.S. 10.10.2. Canada 10.11. North America Newborn Screening Market Analysis, by Country 10.12. U.S. Newborn Screening Market Forecast, by Products 10.12.1. New-born screening instruments 10.12.2. New-born screening Reagents & Assay kits 10.13. U.S. Newborn Screening Market Forecast, by Test Type 10.13.1. Hearing screen test 10.13.2. Critical congenital heart disease Test 10.13.3. Dry blood spot test 10.14. U.S. Newborn Screening Market Forecast, by Technology 10.14.1. Hearing screen technology 10.14.2. Electrophoresis 10.14.3. Tandem Mass Spectrometry 10.14.4. Pulse Oximetry Technology 10.14.5. DNA based assays 10.14.6. Enzymes & Immunoassay 10.15. Canada Newborn Screening Market Forecast, by Products 10.15.1. New-born screening instruments 10.15.2. New-born screening Reagents & Assay kits 10.16. Canada Newborn Screening Market Forecast, by Test Type 10.16.1. Hearing screen test 10.16.2. Critical congenital heart disease Test 10.16.3. Dry blood spot test 10.17. Canada Newborn Screening Market Forecast, by Technology 10.17.1. Hearing screen technology 10.17.2. Electrophoresis 10.17.3. Tandem Mass Spectrometry 10.17.4. Pulse Oximetry Technology 10.17.5. DNA based assays 10.17.6. Enzymes & Immunoassay 10.18. North America Newborn Screening Market Attractiveness Analysis 10.18.1. By-Products 10.18.2. By Test Type 10.18.3. By Technology 10.19. PEST Analysis 11. Europe Newborn Screening Market Analysis 11.1. Key Findings 11.2. Europe Newborn Screening Market Overview 11.3. Europe Newborn Screening Market Value Share Analysis, by Products 11.4. Europe Newborn Screening Market Forecast, by Products 11.4.1. New-born screening instruments 11.4.2. New-born screening Reagents & Assay kits 11.5. Europe Newborn Screening Market Value Share Analysis, by Test Type 11.6. Europe Newborn Screening Market Forecast, by Test Type 11.6.1. Hearing screen test 11.6.2. Critical congenital heart disease Test 11.6.3. Dry blood spot test 11.7. Europe Newborn Screening Market Value Share Analysis, by Technology 11.8. Europe Newborn Screening Market Forecast, by Technology 11.8.1. Hearing screen technology 11.8.2. Electrophoresis 11.8.3. Tandem Mass Spectrometry 11.8.4. Pulse Oximetry Technology 11.8.5. DNA based assays 11.8.6. Enzymes & Immunoassay 11.9. Europe Newborn Screening Market Value Share Analysis, by Country 11.10. Europe Newborn Screening Market Forecast, by Country 11.10.1. Germany 11.10.2. U.K. 11.10.3. France 11.10.4. Italy 11.10.5. Spain 11.10.6. Rest of Europe 11.11. Europe Newborn Screening Market Analysis, by Country/ Sub-region 11.12. Germany Newborn Screening Market Forecast, by Products 11.12.1. New-born screening instruments 11.12.2. New-born screening Reagents & Assay kits 11.13. Germany Newborn Screening Market Forecast, by Test Type 11.13.1. Hearing screen test 11.13.2. Critical congenital heart disease Test 11.13.3. Dry blood spot test 11.14. Germany Newborn Screening Market Forecast, by Technology 11.14.1. Hearing screen technology 11.14.2. Electrophoresis 11.14.3. Tandem Mass Spectrometry 11.14.4. Pulse Oximetry Technology 11.14.5. DNA based assays 11.14.6. Enzymes & Immunoassay 11.15. U.K. Newborn Screening Market Forecast, by Products 11.15.1. New-born screening instruments 11.15.2. New-born screening Reagents & Assay kits 11.16. U.K. Newborn Screening Market Forecast, by Test Type 11.16.1. Hearing screen test 11.16.2. Critical congenital heart disease Test 11.16.3. Dry blood spot test 11.17. U.K. Newborn Screening Market Forecast, by Technology 11.17.1. Hearing screen technology 11.17.2. Electrophoresis 11.17.3. Tandem Mass Spectrometry 11.17.4. Pulse Oximetry Technology 11.17.5. DNA based assays 11.17.6. Enzymes & Immunoassay 11.18. France Newborn Screening Market Forecast, by Products 11.18.1. New-born screening instruments 11.18.2. New-born screening Reagents & Assay kits 11.19. France Newborn Screening Market Forecast, by Test Type 11.19.1. Hearing screen test 11.19.2. Critical congenital heart disease Test 11.19.3. Dry blood spot test 11.20. France Newborn Screening Market Forecast, by Technology 11.20.1. Hearing screen technology 11.20.2. Electrophoresis 11.20.3. Tandem Mass Spectrometry 11.20.4. Pulse Oximetry Technology 11.20.5. DNA based assays 11.20.6. Enzymes & Immunoassay 11.21. Italy Newborn Screening Market Forecast, by Products 11.21.1. New-born screening instruments 11.21.2. New-born screening Reagents & Assay kits 11.22. Italy Newborn Screening Market Forecast, by Test Type 11.22.1. Hearing screen test 11.22.2. Critical congenital heart disease Test 11.22.3. Dry blood spot test 11.23. Italy Newborn Screening Market Forecast, by Technology 11.23.1. Hearing screen technology 11.23.2. Electrophoresis 11.23.3. Tandem Mass Spectrometry 11.23.4. Pulse Oximetry Technology 11.23.5. DNA based assays 11.23.6. Enzymes & Immunoassay 11.24. Spain Newborn Screening Market Forecast, by Products 11.24.1. New-born screening instruments 11.24.2. New-born screening Reagents & Assay kits 11.25. Spain Newborn Screening Market Forecast, by Test Type 11.25.1. Hearing screen test 11.25.2. Critical congenital heart disease Test 11.25.3. Dry blood spot test 11.26. Spain Newborn Screening Market Forecast, by Technology 11.26.1. Hearing screen technology 11.26.2. Electrophoresis 11.26.3. Tandem Mass Spectrometry 11.26.4. Pulse Oximetry Technology 11.26.5. DNA based assays 11.26.6. Enzymes & Immunoassay 11.27. Rest of Europe Newborn Screening Market Forecast, by Products 11.27.1. New-born screening instruments 11.27.2. New-born screening Reagents & Assay kits 11.28. Rest of Europe Newborn Screening Market Forecast, by Test Type 11.28.1. Hearing screen test 11.28.2. Critical congenital heart disease Test 11.28.3. Dry blood spot test 11.29. Rest of Europe Newborn Screening Market Forecast, by Technology 11.29.1. Hearing screen technology 11.29.2. Electrophoresis 11.29.3. Tandem Mass Spectrometry 11.29.4. Pulse Oximetry Technology 11.29.5. DNA based assays 11.29.6. Enzymes & Immunoassay 11.30. Europe Newborn Screening Market Attractiveness Analysis 11.30.1. By-Products 11.30.2. By Test Type 11.30.3. By Technology 11.31. PEST Analysis 12. Asia Pacific Newborn Screening Market Analysis 12.1. Key Findings 12.2. Asia Pacific Newborn Screening Market Overview 12.3. Asia Pacific Newborn Screening Market Value Share Analysis, by Products 12.4. Asia Pacific Newborn Screening Market Forecast, by Products 12.4.1. New-born screening instruments 12.4.2. New-born screening Reagents & Assay kits 12.5. Asia Pacific Newborn Screening Market Value Share Analysis, by Test Type 12.6. Asia Pacific Newborn Screening Market Forecast, by Test Type 12.6.1. Hearing screen test 12.6.2. Critical congenital heart disease Test 12.6.3. Dry blood spot test 12.7. Asia Pacific Newborn Screening Market Value Share Analysis, by Technology 12.8. Asia Pacific Newborn Screening Market Forecast, by Technology 12.8.1. Hearing screen technology 12.8.2. Electrophoresis 12.8.3. Tandem Mass Spectrometry 12.8.4. Pulse Oximetry Technology 12.8.5. DNA based assays 12.8.6. Enzymes & Immunoassay 12.9. Asia Pacific Newborn Screening Market Value Share Analysis, by Country 12.10. Asia Pacific Newborn Screening Market Forecast, by Country 12.10.1. China 12.10.2. India 12.10.3. Japan 12.10.4. ASEAN 12.10.5. Rest of Asia Pacific 12.11. Asia Pacific Newborn Screening Market Analysis, by Country/ Sub-region 12.12. China Newborn Screening Market Forecast, by Products 12.12.1. New-born screening instruments 12.12.2. New-born screening Reagents & Assay kits 12.13. China Newborn Screening Market Forecast, by Test Type 12.13.1. Hearing screen test 12.13.2. Critical congenital heart disease Test 12.13.3. Dry blood spot test 12.14. China Newborn Screening Market Forecast, by Technology 12.14.1. Hearing screen technology 12.14.2. Electrophoresis 12.14.3. Tandem Mass Spectrometry 12.14.4. Pulse Oximetry Technology 12.14.5. DNA based assays 12.14.6. Enzymes & Immunoassay 12.14.7. 12.15. India Newborn Screening Market Forecast, by Products 12.15.1. New-born screening instruments 12.15.2. New-born screening Reagents & Assay kits 12.16. India Newborn Screening Market Forecast, by Test Type 12.16.1. Hearing screen test 12.16.2. Critical congenital heart disease Test 12.16.3. Dry blood spot test 12.17. India Newborn Screening Market Forecast, by Technology 12.17.1. Hearing screen technology 12.17.2. Electrophoresis 12.17.3. Tandem Mass Spectrometry 12.17.4. Pulse Oximetry Technology 12.17.5. DNA based assays 12.17.6. Enzymes & Immunoassay 12.17.7. 12.18. Japan Newborn Screening Market Forecast, by Products 12.18.1. New-born screening instruments 12.18.2. New-born screening Reagents & Assay kits 12.19. Japan Newborn Screening Market Forecast, by Test Type 12.19.1. Hearing screen test 12.19.2. Critical congenital heart disease Test 12.19.3. Dry blood spot test 12.20. Japan Newborn Screening Market Forecast, by Technology 12.20.1. Hearing screen technology 12.20.2. Electrophoresis 12.20.3. Tandem Mass Spectrometry 12.20.4. Pulse Oximetry Technology 12.20.5. DNA based assays 12.20.6. Enzymes & Immunoassay 12.21. ASEAN Newborn Screening Market Forecast, by Products 12.21.1. New-born screening instruments 12.21.2. New-born screening Reagents & Assay kits 12.22. ASEAN Newborn Screening Market Forecast, by Test Type 12.22.1. Hearing screen test 12.22.2. Critical congenital heart disease Test 12.22.3. Dry blood spot test 12.23. ASEAN Newborn Screening Market Forecast, by Technology 12.23.1. Hearing screen technology 12.23.2. Electrophoresis 12.23.3. Tandem Mass Spectrometry 12.23.4. Pulse Oximetry Technology 12.23.5. DNA based assays 12.23.6. Enzymes & Immunoassay 12.24. Rest of Asia Pacific Newborn Screening Market Forecast, by Products 12.24.1. New-born screening instruments 12.24.2. New-born screening Reagents & Assay kits 12.25. Rest of Asia Pacific Newborn Screening Market Forecast, by Test Type 12.25.1. Hearing screen test 12.25.2. Critical congenital heart disease Test 12.25.3. Dry blood spot test 12.26. Rest of Asia Pacific Newborn Screening Market Forecast, by Technology 12.26.1. Hearing screen technology 12.26.2. Electrophoresis 12.26.3. Tandem Mass Spectrometry 12.26.4. Pulse Oximetry Technology 12.26.5. DNA based assays 12.26.6. Enzymes & Immunoassay 12.27. Asia Pacific Newborn Screening Market Attractiveness Analysis 12.27.1. By-Products 12.27.2. By Test Type 12.27.3. By Technology 12.28. PEST Analysis 13. Middle East & Africa Newborn Screening Market Analysis 13.1. Key Findings 13.2. The Middle East & Africa Newborn Screening Market Overview 13.3. The Middle East & Africa Newborn Screening Market Value Share Analysis, by Products 13.4. The Middle East & Africa Newborn Screening Market Forecast, by Products 13.4.1. New-born screening instruments 13.4.2. New-born screening Reagents & Assay kits 13.5. The Middle East & Africa Newborn Screening Market Value Share Analysis, by Test Type 13.6. The Middle East & Africa Newborn Screening Market Forecast, by Test Type 13.6.1. Hearing screen test 13.6.2. Critical congenital heart disease Test 13.6.3. Dry blood spot test 13.7. The Middle East & Africa Newborn Screening Market Value Share Analysis, by Technology 13.8. The Middle East & Africa Newborn Screening Market Forecast, by Technology 13.8.1. Hearing screen technology 13.8.2. Electrophoresis 13.8.3. Tandem Mass Spectrometry 13.8.4. Pulse Oximetry Technology 13.8.5. DNA based assays 13.8.6. Enzymes & Immunoassay 13.8.7. 13.9. The Middle East & Africa Newborn Screening Market Value Share Analysis, by Country 13.10. The Middle East & Africa Newborn Screening Market Forecast, by Country 13.10.1. GCC 13.10.2. South Africa 13.10.3. Rest of Middle East & Africa 13.11. The Middle East & Africa Newborn Screening Market Analysis, by Country/ Sub-region 13.12. GCC Newborn Screening Market Forecast, by Products 13.12.1. New-born screening instruments 13.12.2. New-born screening Reagents & Assay kits 13.13. GCC Newborn Screening Market Forecast, by Test Type 13.13.1. Hearing screen test 13.13.2. Critical congenital heart disease Test 13.13.3. Dry blood spot test 13.14. GCC Newborn Screening Market Forecast, by Technology 13.14.1. Hearing screen technology 13.14.2. Electrophoresis 13.14.3. Tandem Mass Spectrometry 13.14.4. Pulse Oximetry Technology 13.14.5. DNA based assays 13.14.6. Enzymes & Immunoassay 13.15. South Africa Newborn Screening Market Forecast, by Products 13.15.1. New-born screening instruments 13.15.2. New-born screening Reagents & Assay kits 13.16. South Africa Newborn Screening Market Forecast, by Test Type 13.16.1. Hearing screen test 13.16.2. Critical congenital heart disease Test 13.16.3. Dry blood spot test 13.17. South Africa Newborn Screening Market Forecast, by Technology 13.17.1. Hearing screen technology 13.17.2. Electrophoresis 13.17.3. Tandem Mass Spectrometry 13.17.4. Pulse Oximetry Technology 13.17.5. DNA based assays 13.17.6. Enzymes & Immunoassay 13.18. Rest of Middle East & Africa Newborn Screening Market Forecast, by Products 13.18.1. New-born screening instruments 13.18.2. New-born screening Reagents & Assay kits 13.19. Rest of Middle East & Africa Newborn Screening Market Forecast, by Test Type 13.19.1. Hearing screen test 13.19.2. Critical congenital heart disease Test 13.19.3. Dry blood spot test 13.20. Rest of Middle East & Africa Newborn Screening Market Forecast, by Technology 13.20.1. Hearing screen technology 13.20.2. Electrophoresis 13.20.3. Tandem Mass Spectrometry 13.20.4. Pulse Oximetry Technology 13.20.5. DNA based assays 13.20.6. Enzymes & Immunoassay 13.20.7. 13.21. Middle East & Africa Newborn Screening Market Attractiveness Analysis 13.21.1. By Products 13.21.2. By Test Type 13.21.3. By Technology 13.22. PEST Analysis 14. Latin America Newborn Screening Market Analysis 14.1. Key Findings 14.2. Latin America Newborn Screening Market Overview 14.3. Latin America Newborn Screening Market Value Share Analysis, by Products 14.4. Latin America Newborn Screening Market Forecast, by Products 14.4.1. New-born screening instruments 14.4.2. New-born screening Reagents & Assay kits 14.5. Latin America Newborn Screening Market Value Share Analysis, by Test Type 14.6. Latin America Newborn Screening Market Forecast, by Test Type 14.6.1. Hearing screen test 14.6.2. Critical congenital heart disease Test 14.6.3. Dry blood spot test 14.7. Latin America Newborn Screening Market Value Share Analysis, by Technology 14.8. Latin America Newborn Screening Market Forecast, by Technology 14.8.1. Hearing screen technology 14.8.2. Electrophoresis 14.8.3. Tandem Mass Spectrometry 14.8.4. Pulse Oximetry Technology 14.8.5. DNA based assays 14.8.6. Enzymes & Immunoassay 14.9. Latin America Newborn Screening Market Value Share Analysis, by Country 14.10. Latin America Newborn Screening Market Forecast, by Country 14.10.1. Brazil 14.10.2. Mexico 14.10.3. Rest of Latin America 14.11. Latin America Newborn Screening Market Analysis, by Country/ Sub-region 14.12. Brazil Newborn Screening Market Forecast, by Products 14.12.1. New-born screening instruments 14.12.2. New-born screening Reagents & Assay kits 14.13. Brazil Newborn Screening Market Forecast, by Test Type 14.13.1. Hearing screen test 14.13.2. Critical congenital heart disease Test 14.13.3. Dry blood spot test 14.14. Brazil Newborn Screening Market Forecast, by Technology 14.14.1. Hearing screen technology 14.14.2. Electrophoresis 14.14.3. Tandem Mass Spectrometry 14.14.4. Pulse Oximetry Technology 14.14.5. DNA based assays 14.14.6. Enzymes & Immunoassay 14.15. Mexico Newborn Screening Market Forecast, by Products 14.15.1. New-born screening instruments 14.15.2. New-born screening Reagents & Assay kits 14.16. Mexico Newborn Screening Market Forecast, by Test Type 14.16.1. Hearing screen test 14.16.2. Critical congenital heart disease Test 14.16.3. Dry blood spot test 14.17. Mexico Newborn Screening Market Forecast, by Technology 14.17.1. Hearing screen technology 14.17.2. Electrophoresis 14.17.3. Tandem Mass Spectrometry 14.17.4. Pulse Oximetry Technology 14.17.5. DNA based assays 14.17.6. Enzymes & Immunoassay 14.18. Rest of Latin America Newborn Screening Market Forecast, by Products 14.18.1. New-born screening instruments 14.18.2. New-born screening Reagents & Assay kits 14.19. Rest of Latin America Newborn Screening Market Forecast, by Test Type 14.19.1. Hearing screen test 14.19.2. Critical congenital heart disease Test 14.19.3. Dry blood spot test 14.20. Rest of Latin America Newborn Screening Market Forecast, by Technology 14.20.1. Hearing screen technology 14.20.2. Electrophoresis 14.20.3. Tandem Mass Spectrometry 14.20.4. Pulse Oximetry Technology 14.20.5. DNA based assays 14.20.6. Enzymes & Immunoassay 14.21. Latin America Newborn Screening Market Attractiveness Analysis 14.21.1. By Products 14.21.2. By Test Type 14.21.3. By Technology 14.22. PEST Analysis 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.3. Company Profiles: Key Players 15.3.1. ZenTech S.A 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Business Strategy 15.3.1.4. Recent Developments 15.3.1.5. Manufacturing Footprint 15.3.2. AB Sciex 15.3.3. Agilent Technologies Inc 15.3.4. Bio-Rad Laboratories Inc 15.3.5. Covidien PLC 15.3.6. GE Healthcare 15.3.7. Masimo Corporation 15.3.8. Medtronic Inc 15.3.9. Natus Medical Incorporated 15.3.10. PerkinElmer Inc 15.3.11. Trivitron Healthcare 15.3.12. Waters Corporation 16. Primary Key Insights